These results may have important implications regarding the role of β-arrestin2 in tumour progression, as they indicate that β-arrestin2 up-regulates E-cadherin expression and down-regulates vimentin expression, thereby participating in EMT. The gene discussed is CDH1; the disease is neoplasm.